Quantum Biopharma Ltd. Approved to Dual List on Upstream
Trading to become available January 14th under 'QNTM' TORONTO, ONTARIO / ACCESSWIRE / January 7, 2025 / Quantum BioPharma Ltd....
Year: 2025
Theralogix Launches TheraCran(R) Max: Dual-Action Defense for Urinary Tract Health
ROCKVILLE, MD / ACCESSWIRE / January 7, 2025 / Theralogix, a trusted leader in the nutritional supplement industry, proudly announces...
Septoplasty or Rhinoplasty? New Jersey Facial Plastic Surgeon Breaks Down the Difference
Dr. Anni Wong explains functional and aesthetic nasal corrections. FREEHOLD, NEW JERSEY / ACCESSWIRE / January 7, 2025 / In...
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented Growth
Walmart Marketplace saw a 60% year-over-year growth in gross merchandise volume, with third-party sellers accounting for over 50% of online...
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
MIAMI, FL / ACCESSWIRE / January 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), an emerging leader in age-reversal science...
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica...
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million
Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Million...
Quris-AI’s Bio-AI Platform Integrated by Merck KGaA, Darmstadt, Germany for Preclinical Small Molecule Drug Safety Evaluation
Quris-AI to Provide Safety Assessments for Small Molecule Drug Candidates Before Initiating Clinical TrialsBOSTON and TEL-AVIV, Israel, Jan. 07, 2025...
Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
GAITHERSBURG, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development...
Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care Organization
WILLMINGTON, Del., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced it...
Walgreens and Visory Health Ink New Deal
Walgreens’ nine million daily shoppers now have access to discounted medication through Visory Health as one of Visory Health’s Featured...
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
Achieved record fourth quarter and full-year 2024 sepsis product revenuesLEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:...
Cyclarity Therapeutics Secures Approval for First-in-Human Clinical Trial
NOVATO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cyclarity Therapeutics is pleased to announce regulatory approval to begin its first-in-human...
Bioxytran Announces Government Interest After Initial BARDA Techwatch Light Meeting
BOSTON, MASSACHUSETTS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing...
CORRECTION – OraQuick® HIV Self-Test Now Approved for Use in Adolescents
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th...
Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission
Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure Requirement...
Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
VANCOUVER, British Columbia and BOSTON, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company...
Ori Biotech Announces First Customer Deliveries of IRO to Leading CDMOs and Commercial CGT Manufacturers
Six months after its unveiling, the IRO platform is now being deployed to customersLONDON, Jan. 07, 2025 (GLOBE NEWSWIRE) --...
QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery with first successful simultaneous 10-target multiplex-screening
QUANTRO’s proprietary time-resolved functional transcriptomic discovery platform accelerates target screening for complex indications in oncology and inflammationQUANTRO CEO Dr. Michael...
Cytrellis Biosystems launches Updated Next-Generation Skin Removal Treatment ellacor® 2.0, fueled by new leadership and financing
WOBURN, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cytrellis Biosystems, Inc., a pioneer in novel medical aesthetic solutions, today announced...